Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature

MLA

Hiroaki Nakamura, et al. “Pegfilgrastim-Associated Large-Vessel Vasculitis Developed during Adjuvant Chemotherapy for Breast Cancer: A Case Report and Review of the Literature.” Journal of Oncology Pharmacy Practice, vol. 26, Mar. 2020, pp. 1785–90. EBSCOhost, https://doi.org/10.1177/1078155220910800.

APA

Hiroaki Nakamura, Jun Nakamura, Ken Sato, Akihiro Iyama, Shun Yamashita, Tomoyo M Nishi, & Yoshimasa Oda. (2020). Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature. Journal of Oncology Pharmacy Practice, 26, 1785–1790. https://doi.org/10.1177/1078155220910800

Chicago

Hiroaki Nakamura, Jun Nakamura, Ken Sato, Akihiro Iyama, Shun Yamashita, Tomoyo M Nishi, and Yoshimasa Oda. 2020. “Pegfilgrastim-Associated Large-Vessel Vasculitis Developed during Adjuvant Chemotherapy for Breast Cancer: A Case Report and Review of the Literature.” Journal of Oncology Pharmacy Practice 26 (March): 1785–90. doi:10.1177/1078155220910800.